Loki Home

Research Interests

Funding Opportunities


UI Login Guest Login

Browse by Investigator Last Name

Browse Research

Photo of David Bender

David Bender

Clinical Associate Professor,  OBGyn

Contact Information

Phone: +1 319 356 2015
Email: david-bender@uiowa.edu


BA, Bowdoin Collge, Brunswick, ME
MD, Medicine, Finch University of Health Sciences, The Chicago Medical School, North Chicago, IL
Residency, Obstetrics and Gynecology, Magee-Women's Hospital, University Health Center of Pittsburgh, Pittsburgh, PA
Fellowship, Gynecologic Oncology, University of Louisville School of Medicine, Louisville, KY
Fellowship, Gynecologic Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA


Primary: OBGyn

Centers and Program Affiliations

Research Interests

MeSH Terms from Publications

Research Summary

Recent Publications

Show publications
  1. Shamshirsaz, A, Buekers, T, Degeest, K, Bender, D, Zamba, G, Goodheart, M. A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival. Int J Gynecol Cancer 21(7):1232-40, 2011. [PubMed]
  2. Girardi, JR, Samuelson, M, Button, A, De Geest, K, Bender, D, Ahmed, A, Goodheart, MJ. The relationship between vascularity, p53 gene mutations and distant metastatic disease in epithelial ovarian carcinoma. GYNECOLOGIC ONCOLOGY 123(2):443-443, NOV 2011.
  3. Clements, A, Engle, D, Shelton, D, Neff, T, Park, S, Bender, D, Ahmed, A, De Geest, K, Button, A, Engelhardt, J, Goodheart, M. Lymphoid enhancing factor 1 (Lef-1) overexpression in epithelial ovarian, fallopian tube and peritoneal cancers and associations with clinical factors. GYNECOLOGIC ONCOLOGY 123(2):437-437, NOV 2011.
  4. Lutgendorf, S, DeGeest, K, Dahmoush, L, Farley, D, Penedo, F, Bender, D, Goodheart, M, Buekers, T, Mendez, L, Krueger, G, Clevenger, L, Lubaroff, D, Sood, A, Cole, S. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 25(2):250-5, 2011. [PubMed]
  5. Lutgendorf, S, Mullen-Houser, E, Russell, D, Degeest, K, Jacobson, G, Hart, L, Bender, D, Anderson, B, Buekers, T, Goodheart, M, Antoni, M, Sood, A, Lubaroff, D. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain Behav Immun 24(8):1231-40, 2010. [PubMed]
  6. Weinrib, A, Sephton, S, Degeest, K, Penedo, F, Bender, D, Zimmerman, B, Kirschbaum, C, Sood, A, Lubaroff, D, Lutgendorf, S. Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer 116(18):4410-9, 2010. [PubMed]
  7. Nadkarni, N, Bender, D, Buekers, T, De Geest, K, Zimmerman, M, Goodheart, M. The role of angiogenic markers in stage III and IV ovarian cancer and their association with mutations of the p53 gene. GYNECOLOGIC ONCOLOGY 116(3):S115-S115, MAR 2010.
  8. Goodheart, MJ, Neff, T, Yeun-Park, S, Liu, X, Xie, W, DeGeest, K, Bender, DP, Buekers, TE, Engelhardt, JF. The role of lymphoid-enhancing factor 1 (Lef-1) in endometrial gland morphogenesis. GYNECOLOGIC ONCOLOGY 112(2):S91-S91, FEB 2009.
  9. Shamshirsaz, AA, Goodheart, M, Zamba, G, Bender, DP, Buekers, TE, DeGeest, K. Primary fallopian tube cancer - 30 years experience at the University of Iowa. OBSTETRICS AND GYNECOLOGY 111(4):54S-54S, APR 2008.
  10. Modesitt, S, Sill, M, Hoffman, J, Bender, D. A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 109(2):182-6, 2008. [PubMed]